BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 25330246)

  • 1. D4 dopamine receptor-specific antagonist improves reversal learning impairment in amphetamine-treated male rats.
    Connolly NP; Gomez-Serrano M
    Exp Clin Psychopharmacol; 2014 Dec; 22(6):557-64. PubMed ID: 25330246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests.
    Bristow LJ; Collinson N; Cook GP; Curtis N; Freedman SB; Kulagowski JJ; Leeson PD; Patel S; Ragan CI; Ridgill M; Saywell KL; Tricklebank MD
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1256-63. PubMed ID: 9400001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choline and Working Memory Training Improve Cognitive Deficits Caused by Prenatal Exposure to Ethanol.
    Waddell J; Mooney SM
    Nutrients; 2017 Sep; 9(10):. PubMed ID: 28961168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sensitizing regimen of amphetamine that disrupts attentional set-shifting does not disrupt working or long-term memory.
    Featherstone RE; Rizos Z; Kapur S; Fletcher PJ
    Behav Brain Res; 2008 May; 189(1):170-9. PubMed ID: 18299157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventral striatal dopamine modulation of different forms of behavioral flexibility.
    Haluk DM; Floresco SB
    Neuropsychopharmacology; 2009 Jul; 34(8):2041-52. PubMed ID: 19262467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ultimate intra-/extra-dimensional attentional set-shifting task for mice.
    Scheggia D; Bebensee A; Weinberger DR; Papaleo F
    Biol Psychiatry; 2014 Apr; 75(8):660-70. PubMed ID: 23810621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal-specific learning impairments after a binge regimen of methamphetamine in rats: possible involvement of striatal dopamine.
    Izquierdo A; Belcher AM; Scott L; Cazares VA; Chen J; O'Dell SJ; Malvaez M; Wu T; Marshall JF
    Neuropsychopharmacology; 2010 Jan; 35(2):505-14. PubMed ID: 19794407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic cocaine but not chronic amphetamine use is associated with perseverative responding in humans.
    Ersche KD; Roiser JP; Robbins TW; Sahakian BJ
    Psychopharmacology (Berl); 2008 Apr; 197(3):421-31. PubMed ID: 18214445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A sensitizing regimen of amphetamine impairs visual attention in the 5-choice serial reaction time test: reversal by a D1 receptor agonist injected into the medial prefrontal cortex.
    Fletcher PJ; Tenn CC; Sinyard J; Rizos Z; Kapur S
    Neuropsychopharmacology; 2007 May; 32(5):1122-32. PubMed ID: 17047670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic treatment with galantamine rescues reversal learning in an attentional set-shifting test after experimental brain trauma.
    Njoku I; Radabaugh HL; Nicholas MA; Kutash LA; O'Neil DA; Marshall IP; Cheng JP; Kline AE; Bondi CO
    Exp Neurol; 2019 May; 315():32-41. PubMed ID: 30711647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A selective role for dopamine D₄ receptors in modulating reward expectancy in a rodent slot machine task.
    Cocker PJ; Le Foll B; Rogers RD; Winstanley CA
    Biol Psychiatry; 2014 May; 75(10):817-24. PubMed ID: 24094512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of short-term abstinence from escalating doses of D-amphetamine on drug and sucrose-evoked dopamine efflux in the rat nucleus accumbens.
    Vacca G; Ahn S; Phillips AG
    Neuropsychopharmacology; 2007 Apr; 32(4):932-9. PubMed ID: 16885936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopaminergic modulation of risk-based decision making.
    St Onge JR; Floresco SB
    Neuropsychopharmacology; 2009 Feb; 34(3):681-97. PubMed ID: 18668030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D2/D3 receptors play a specific role in the reversal of a learned visual discrimination in monkeys.
    Lee B; Groman S; London ED; Jentsch JD
    Neuropsychopharmacology; 2007 Oct; 32(10):2125-34. PubMed ID: 17299511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D4 receptors in psychostimulant addiction.
    Di Ciano P; Grandy DK; Le Foll B
    Adv Pharmacol; 2014; 69():301-21. PubMed ID: 24484981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of post-training heroin and d-amphetamine on consolidation of win-stay learning and fear conditioning.
    Leri F; Nahas E; Henderson K; Limebeer CL; Parker LA; White NM
    J Psychopharmacol; 2013 Mar; 27(3):292-301. PubMed ID: 23325371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute quetiapine dose-dependently exacerbates anhedonia induced by withdrawal from escalating doses of d-amphetamine.
    Zhornitsky S; Potvin S; Stip E; Rompré PP
    Eur Neuropsychopharmacol; 2010 Oct; 20(10):695-703. PubMed ID: 20605419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of hippocampal NMDA receptors and nucleus accumbens D1 receptors in the amphetamine-produced conditioned place preference in rats.
    Tan SE
    Brain Res Bull; 2008 Dec; 77(6):412-9. PubMed ID: 18929625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-Amphetamine remediates attentional performance in rats with dorsal prefrontal lesions.
    Chudasama Y; Nathwani F; Robbins TW
    Behav Brain Res; 2005 Mar; 158(1):97-107. PubMed ID: 15680198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naltrexone attenuates amphetamine-induced locomotor sensitization in the rat.
    Häggkvist J; Björkholm C; Steensland P; Lindholm S; Franck J; Schilström B
    Addict Biol; 2011 Jan; 16(1):20-9. PubMed ID: 20192948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.